Display Settings:

Format

Send to:

Choose Destination
Neurosci Biobehav Rev. 2012 Mar;36(3):989-1000. doi: 10.1016/j.neubiorev.2011.12.011. Epub 2012 Jan 2.

NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders.

Author information

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA. zorumskc@wustl.edu

Abstract

N-methyl-D-aspartate receptors (NMDARs) are key components of neural signaling, playing roles in synaptic transmission and in the synaptic plasticity thought to underlie learning and memory. NMDAR activation can also have neurotoxic consequences contributing to several forms of neurodegeneration. Additionally, NMDARs can modulate neuronal function and regulate the ability of synapses to undergo synaptic plasticity. Evidence gathered over the past 20 years strongly supports the idea that untimely activation of NMDARs impairs the induction of long-term potentiation (LTP) by a form of metaplasticity. This metaplasticity can be triggered by multiple stimuli including physiological receptor activation, and metabolic and behavioral stressors. These latter findings raise the possibility that NMDARs contribute to cognitive dysfunction associated with neuropsychiatric disorders. This paper examines NMDAR metaplasticity and its potential role in cognition. Recent studies using NMDAR antagonists for therapeutic purposes also raise the possibility that metaplasticity may contribute to clinical effects of certain drugs.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PMID:
22230702
[PubMed - indexed for MEDLINE]
PMCID:
PMC3288588
Free PMC Article

Images from this publication.See all images (4)Free text

Figure 1
Figure 2
Figure 3
Figure 4
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Write to the Help Desk